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Introduction
Obesity is a complex, multi-system disorder that results from a 
positive energy imbalance. The World Health Organization (WHO) 
classifies obesity based on body mass index (BMI), measured as 
weight (kg) divided by height squared (m2)1 (Table I).
The overall prevalence of overweight and obesity is high in South 
Africa, with more than 29% of men and 56% of women being 
obese.2 BMI was found to be higher in people living in urban 
areas and in those with increasing age. An analysis of medical 
claims data for South Africans during 2010 associated obesity 
with significantly increased healthcare expenditure.3
Objectives of this presentation
In view of the increasing prevalence of this disorder, anaesthe-
siologists need to be skilled in the perioperative management of 
this patient population.
This manuscript will highlight the:
•	 Preoperative assessment of adult obese patients, in particular 
those requiring further cardiac and respiratory testing.
•	 Safe perioperative care that encourages better patient 
outcomes, early mobilisation and shortened length of hospital 
stay.
•	 The obese patient for ambulatory surgery.
Preoperative assessment
A preoperative assessment is important in identifying and 
treating co-morbidities, and allows for the advanced planning 
of intraoperative and postoperative care. Ideally, it should be 
performed 6-12 weeks prior to surgery, and must involve a 
multidisciplinary team approach. 
Table II details co-morbidities that are frequently found in obese 
patients.
The distribution of adipose tissue, rather than absolute weight 
or BMI, appears to be more clinically relevant in predicting 
disease. Centrally distributed adipose tissue (android obesity) is 
associated with a higher morbidity than peripherally distributed 
adipose tissue (gynaecoid obesity).
Cardiovascular system
The risk of adverse perioperative cardiac events in obese patients 
relates to the underlying cardiac disease, the presence of co-
morbidities and the type of surgery.4   
Obesity is associated with increased atherosclerotic cardiac risk, 
probably contributing to coronary artery disease. Heart failure is 
also multifactorial and is most evident in severely obese patients. 
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Table II: Co-morbidities frequently found in obese patients
Cardiovascular system Systemic hypertension, atherosclerosis, 
coronary artery disease, heart failure, 
pulmonary hypertension, arrhythmias, 
deep vein thrombosis and varicose veins
Respiratory system Airway changes, obesity hypoventilation 
syndrome, obstructive sleep apnoea and 
restrictive lung disease
Gastrointestinal system Hepatosteatosis, gallstones and hiatus 
hernia
Metabolic Metabolic syndrome and diabetes mellitus
Musculoskeletal system Osteoarthritis of the weight-bearing joints 
and compression fractures
Neurological system Cerebrovascular disease, neuropathies 
(e.g. carpal tunnel syndrome) and 
psychological problems
Other Malignancy (e.g. endometrial, breast, 
colon, oesophageal and renal), skin 
infections and lymphoedema
Table I: Body mass index classification according to the World Health 
Organization
Weight class BMI (kg/m2)
Overweight 25-29.9
Obese > 30
Obesity grade 1 30-34.9
Obesity grade 2 (morbidly obese) 35-39.9
Obesity grade 3 (severe obesity) > 40
Obesity grade 4 (super obese) > 50
Obesity grade 5 (super-super obese) > 60
BMI: body mass index
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Patients with obesity cardiomyopathy (heart failure due to 
obesity) have diastolic heart failure, but systolic dysfunction may 
be present. Pulmonary hypertension may lead to cor pulmonale.
Cardiac function may be difficult to elicit from the clinical history 
as patient mobility is often limited. A clinical examination can be 
unreliable as heart sounds are muffled, jugular venous pressure 
may be obscured and peripheral oedema occurs commonly. 
Functional capacity should be assessed according to the patient’s 
ability to undertake daily living activities. Those who are able to 
perform activities requiring four metabolic equivalents have 
moderate functional capacity.1
The Revised Cardiac Risk Index is used to assess cardiac risk in 
patients undergoing non-cardiac surgery. The six risk factors 
identified are high-risk surgery, coronary artery disease (CAD), 
congestive cardiac failure, cerebrovascular disease, insulin-
dependent diabetes mellitus and renal dysfunction. This risk 
stratification should be applied to obese patients preoperatively. 
Figure 1 depicts the cardiac and pulmonary algorithm assessment 
necessary for elective non-cardiac surgery in severely obese 
patients.4
The presence of cardiovascular symptoms, functional capacity 
and cardiac risk analysis will determine whether or not formal 
testing, beyond a chest X-ray and electrocardiography is 
required.4 
Role of further testing
Cardiopulmonary exercise testing is useful in patients who can 
exercise. Morbid obesity may be associated with a reduced V02 
max (maximal aerobic capacity), exercise-induced hypertension 
and a slower heart rate recovery (decreased vagal tone).5 
Tests used in patients with restricted exercise capacity have 
limitations. Transthoracic dobutamine echocardiography has 
a high negative predictive value, but obtaining an adequate 
window may be difficult in obese patients. Transoesophageal 
stress echocardiography accurately assesses the heart, but 
requires patient sedation. Cardiac catheterisation to diagnose 
CAD may be limited by weight restrictions and image quality, 




An enlarged tongue and excessive adipose tissue deposition 
within the pharyngeal structures, face, neck and thorax may 
result in difficulty in mask ventilation, airway lumen narrowing 
and difficult surgical airway access.6 However, there is poor 
correlation between difficult intubation and BMI alone. The 
most significant predictors of difficult laryngoscopy and tracheal 
intubation include a reduced mouth opening, limited neck 
extension and temperomandibular joint movement, a large 
neck circumference (> 40cm), a Mallampati score > 3 and a 
thyromental distance < 6 cm. 
Respiratory system
Obese patients have an increased basal O2 consumption, CO2 
production and minute ventilation. Their lung volumes are 
reduced, most notably functional residual capacity (FRC), which 
approaches residual volume. If the FRC falls below closing 
Comprehensive history, clinical examination and laboratory investigations 
Low-risk patient Step1 Y Proceed with surgery 
N 
One risk factor for CAD 
Pulmonary conditions 
12-lead ECG : 
•    If signs of RVH, consider pulmonary      
     hypertension 
•    If signs of LBBB, consider CAD Y 
Y 
CXR, consider ABG 
Good functional capacity Proceed with surgery Y 
N 






Step5 Decreased left ventricular systolic 
function 




ABG: arterial blood gas, CAD: coronary artery disease, CXR: chest X-ray, ECG: electrocardiogram, LBBB: left bundle branch block, N: no, RVH: right ventricular hypertrophy, Y: yes 
Figure I: Cardiac and pulmonary algorithm assessment for elective non-cardiac surgery in severely obese patients4
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capacity, it may lead to atelectasis, a ventilation/perfusion 
mismatch and impaired oxygenation. There is also reduced chest 
wall compliance and increased airway resistance.
Respiratory function should be established from the history 
and examination. A chest X-ray, arterial blood gas analysis and 
pulmonary function tests (PFT) should be selectively performed 
where clinically indicated. PFT is typically associated with a 
restrictive pattern, but may also demonstrate an obstructive 
pattern. Any reversible obstructive deficit should be optimised 
preoperatively, and smoking cessation for > 8 weeks encouraged.
Obstructive sleep apnoea (OSA) is the complete cessation 
of airflow for > 10 seconds, and is strongly associated with 
obesity. The STOP-Bang [snoring, tiredness during daytime, 
observed apnoea, high blood pressure, body mass index, age, 
neck circumference (> 40 cm for females and 43 cm for males) 
and gender (males)] score is validated in obese patients when 
identifying OSA.7 A score of > 3 has been shown to have a high 
sensitivity for detecting OSA and a score of 5-8 identifies a high 
probability of moderate to severe OSA.7 Patients should then be 
referred for polysomnography, and if positive for OSA, optimised 
with continuous positive airway pressure (CPAP), weight loss and 
the use of mandibular advancement appliances for 6-12 weeks 
prior to surgery.8
Obesity hypoventilation syndrome (OHS) is defined as a 
combination of obesity (BMI > 30 kg/m2), daytime hypercapnia 
(PaCO2 < 45 mmHg) and sleep-disordered breathing.9 A serum 
bicarbonate of > 27 mmol/l is associated with OHS. Treatment of 
OHS with noninvasive ventilation preoperatively may decrease 
patient morbidity. 
Other baseline investigations
Baseline blood tests in obese patients include a full blood count, 
electrolyte profile, and renal, liver and thyroid function tests. 
Perioperative management of the bariatric patient
Premedication
In view of the high incidence of OSA, sedative premedication 
should be avoided. If administered, continuous patient 
monitoring must then be ensured. If there is a history of reflux or 
co-morbidities such as diabetes, it may be prudent to prescribe 
antacid prophylaxis. The risk of venous thromboembolism 
in obese patients warrants the use of appropriately sized 
compression stockings, low-molecular-weight heparin and 




Bariatric patients should be managed at a facility that is 
appropriately equipped and staffed, and ideally, local guidelines 
should be in place. Obesity-specific equipment includes ward 
equipment, trolleys for transport and in theatre, an operating 
table with side extensions, hoists, prone turners, sheet sliders 
and padding equipment. The maximum table weight must be 
known and adhered to. If a bariatric table is unavailable, two 
operating tables could be placed together.
Routine monitoring may be difficult. Even when appropriately 
sized blood pressure (BP) cuffs are used, the readings may be 
inaccurate due to a poor upper arm fit. Alternative sites for BP 
cuff placement (the wrist or ankle) should be considered. An 
ultrasound should be available to facilitate possible difficult 
intravenous (peripheral or central) access and regional 
anaesthesia.
Induction and airway management
The safest transfer is one where the unpremedicated patient 
positions him- or herself on the operating table. The primary 
modifiable factors to optimise induction and the airway are 
patient position, preoxygenation and apnoeic oxygenation.10 
The head-elevated laryngoscopy position or ramp-up position is 
encouraged. This position, which uses 25° back or head elevation, 
ensures that the sternal notch and external auditory meatus lie in 
the same horizontal plane. This, in conjunction with the reverse 
Trendelenburg position (to allow for downward displacement of 
the abdomen and breasts), facilitates airway management and 
ventilation. Preoxygenation for at least five minutes using a close-
fitting mask, with a fraction of inspired oxygen concentration of 
0.8-1, and CPAP up to 10 cmH2O increases apnoea time.6 Rapid 
sequence induction is not routine practice in the absence of co-
morbidities, as obesity itself has not been associated with an 
increased risk of pulmonary aspiration. 
Awake intubation, using fibre-optic bronchoscopy or video 
laryngoscopy is recommended in patients with an anticipated 
difficult airway. Judicial use of sedation and nebulised local 
anaesthetics (4% lignocaine) has been successful. Nerve blocks 
may be challenging, but ultrasound may assist. 
Supraglottic devices are advocated for use in the moderately 
obese patient undergoing peripheral surgery, and are well 
established in the failed airway algorithm. However, owing to 
high peak inspiratory pressure during ventilation, laryngeal 
mask airway (LMA) leak pressure should guide the decision on 
which of these to use:10 LMA Classic® < i-gel™ < LMA Supreme® 
< LMA Proseal®.
Ventilation
The evidence base concerning the most efficacious ventilation 
strategy in this patient population is weak. However, there is 
evidence that an improvement in oxygenation and respiratory 
system compliance occurs when multiple recruitment 
manoeuvres with ventilation are combined with positive-end 
expiratory pressure.11 Furthermore, lung-protective ventilation 
strategies should be employed, with tidal volumes based on 
ideal body weight (IBW), rather than total body weight (TBW). 
Positioning
The supine position is not well tolerated by obese patients, and 
has been associated with cardiorespiratory decompensation 
(obesity supine death syndrome). A left tilt of the bed or 
the placement of a wedge will prevent compression of the 
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inferior vena cava.12 The Trendelenburg position reduces lung 
compliance and results in patient autotransfusion, which places 
further strain on the heart. The prone and lateral decubitus 
positions are well tolerated, provided the upper chest and pelvis 
are well supported, and there is appropriate padding of the soft 
tissue and pressure points. Prolonged surgery in the lithotomy 
position places patients at risk of venous stasis, compartment 
syndrome of the legs and transient neurological symptoms.
Anaesthetic pharmacology and obesity
Owing to the changes in the pharmacokinetic and pharmaco-
dynamic properties of drugs, dosing scalars other than TBW 
must be considered.13
Lean body weight (LBW) is the most appropriate dosing scalar for 
the majority of anaesthetic agents.14 LBW is correlated to cardiac 
output and drug clearance, and is approximately 20-30% of IBW. 
IBW (kg) is approximately calculated using the Broca formula: 
height (cm) – 100 (males) and height (cm) – 105 (females).15 
James and Janmahasatian devised the LBW equations.16,17 
Table III details the recommended dosing scalars for morbidly 
obese patients.13
Desflurane and sevoflurane are associated with faster recovery 
times in bariatric patients, compared to other volatile agents. 
This is because of the lower blood-gas and oil-gas partition 
coefficients. Any clinical advantage of desflurane over 
sevoflurane has not been found in studies.
The use of dexmedetomidine has not been investigated in this 
patient population. However, in view of the co-morbidities, a 
lower induction dose may be prudent. Sugammadex has been 
shown to be significantly faster in reversing rocuronium-induced 
neuromuscular blockade than neostigmine.18 At a train of four 
ratio of 2:4, a dose of 2 mg/kg of IBW + 40% is recommended.19
Postoperative nausea and vomiting prophylaxis should be given.
There is no consensus in obese patients, but a recent study 
suggests that the use of adjusted body weight with the Schnider 
and Marsh models is more clinically accurate, compared to other 
propofol target-controlled infusion (TCI) models.20 However, 
the use of propofol TCI in obese patients should be guided by 
bispectral index monitoring and haemodynamic effect. 
Postoperative management
Patients should be extubated in the semi-upright position when 
fully awake, following complete reversal of neuromuscular 
blockade. Immediate CPAP post extubation maintains lung 
function in patients with OSA. The principles of postoperative pain 
management are the use of opioid-sparing multimodal analgesic 
strategies which include local anaesthetics, paracetamol, 
nonsteroidal anti-inflammatory drugs, transcutaneous electrical 
nerve stimulation and other modalities.21 Patient-controlled 
analgesia with intravenous morphine (dosed to IBW) is safe 
and effective, provided that background infusions are avoided. 
Pregabalin is playing an increasing role as a component of 
multimodal analgesia. 
Regional anaesthesia
Technical challenges and local anaesthetic drug dosing are 
important considerations. The identification of appropriate 
landmarks, positioning of the patient prior to performing 
the block and use of the correct length equipment provide 
challenges. The sitting position facilitates landmark location 
for neuraxial techniques. Palpating on a line between the 
cervical vertebrae and gluteal cleft should identify the midline. 
Ultrasonography assists in the identification of the midline by 
visualisation of the spinous process and estimated depth from 
the skin to the epidural space. When changing from the sitting 
to the lateral position, epidural catheters pull back from the 
epidural space, and therefore should be advanced at least 4 cm 
into the epidural space.22 Ultrasonography also assists in the 
performance of peripheral nerve blocks.
Neuraxial techniques for the obese parturient include epidural 
or combined spinal epidural for labour analgesia. These should 
be initiated early in labour, and can be used for anaesthesia if the 
patient requires a Caesarian section.23
The dose of local anaesthetics in neuraxial techniques is reduced 
owing to the reduced epidural space and cerebrospinal fluid 
volume. This is exaggerated in the obese parturient. There is no 
consensus over the appropriate dose to be used.
Table III: Recommended dosing scalars for morbidly obese patients13
Dosing scalar Comments
Induction agents
Thiopental LBW Use TBW for continuous infusion 
or maintenance dosingPropofol LBW
Etomidate LBW Use in septic patients is 
controversial
Opioids
Fentanyl LBW Titrate to effect
Alfentanil LBW
Sufentanil LBW
Remifentanil LBW TBW dosing may result in 
significant hypotension and/or 
bradycardia
Muscle relaxants
Succinylcholine TBW The incidence of myopathy is low 
in morbidly obese patients
Rocuronium LBW/IBW IBW dosing results in a shorter 
duration of actionVecuronium LBW/IBW
Cisatracurium LBW/IBW
Atracurium LBW/IBW Fast administration may result in 
histamine release
Pancuronium BSA Do not use. The duration of action 
is too long.
Heparins There is 
uncertainty as 
to whether or 
not LBW is the 
appropriate 
dosing scalar
Still controversial. Dose reponse 
in the obese has not been 
established.
IBW:  ideal body weight, LBW: lean body weight, TBW: total body weight,  
BSA: body surface area
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Bariatric patient for ambulatory surgery
Factors that contribute to appropriate patient selection for 
ambulatory surgery include patient-related, surgery-related, 
anaesthesia-related and venue-related factors.24 Therefore, 
BMI alone should not be the sole determinant of suitability for 
ambulatory surgery.
Patient factors
Patients with a BMI > 50 kg/m2 may have a higher risk of 
perioperative complications. However, ambulatory surgery 
appears to be safe in patients with a BMI < 40 kg/m2  with 
controlled co-morbidities. Patients with severe cardiorespiratory 
pathology are unsuitable. Patients with OSA and optimised co-
morbidities may be considered if pain relief postoperatively can 
be provided with simple analgesics and minimal opioid use, and 
the patients are compliant with CPAP post discharge.24 
Surgical factors
Surgical factors include invasiveness of surgery, surgical 
experience and duration. Antibiotic and venous thrombo-
embolism prophylaxis must be prescribed. There is a paucity of 
evidence for ambulatory surgery in obese patients. Hence, an 
individualised patient approach should be utilised.
Conclusion
The “obesity paradox” is a recent phenomenon that has been 
highlighted. It implies that although obesity is associated with 
the development of many disease processes, after a person 
has acquired a disease state, a higher BMI may protect against 
downstream adverse outcomes in acute and chronic disease 
states.25 This obesity survival advantage is known as the obesity 
paradox. The presence of this and its relevance on morbidity 
and mortality in obese patients is currently the subject of much 
debate in the medical field.
However, the number of morbidly obese patients presenting 
for non-bariatric surgery is increasing, and this population is at 
an increased risk of perioperative complications. Preoperative 
assessment and optimisation of associated pathological 
conditions, in conjunction with perioperative management by a 
multidisciplinary team, are essential to optimise patient outcome 
and reduce healthcare costs. 
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